SNOA logo

Sonoma Pharmaceuticals (SNOA) EBITDA

Annual EBITDA

-$4.53 M
-$80.00 K-1.80%

March 31, 2024

Summary

Performance

1-Year Change

-1.8%

3-Year Change

-40.44%

5-Year Change

+58.31%

15-Year Change

+64.33%

SNOA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.85%
SNOA annual EBITDA is higher than 73.85% of companies in Healthcare sector

High & Low

All-time High

$5.08 M
SNOA annual EBITDA is currently -189.13% below its historical high of $5.08 million

3-Year Low

-$5.70 M

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
SNOA previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

N/A
SNOA next annual earnings announcement has not yet been scheduled

OtherSNOAprofitabilitymetrics:

Annual Revenue

$12.73 M
SNOA annual revenue is $12.73 million

Annual Net Income

-$4.83 M
SNOA annual net profit is -$4.83 million

Annual EBIT

-$4.70 M
SNOA annual earnings before interest & taxes is -$4.70 million

Annual EPS

-$10.60
SNOA annual earnings per share is -$10.60

Quarterly EBITDA

-$998.00 K
-$183.00 K-22.45%

December 31, 2024

Summary

Performance

3-Month Change

-22.45%

1-Year Change

-24.91%

3-Year Change

+10.33%

5-Year Change

+10.33%

SNOA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.07%
SNOA quarterly EBITDA is higher than 69.07% of companies in Healthcare sector

High & Low

All-time High

$7.53 M
SNOA quarterly EBITDA is currently -113.25% below its historical high of $7.53 million

3-Year Low

-$3.01 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
SNOA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
SNOA next earnings announcement is scheduled for Feb 7, 2025

OtherSNOAprofitabilitymetrics:

Quarterly Revenue

$3.56 M
SNOA quarterly revenue is $3.56 million

Quarterly Net Income

-$928.00 K
SNOA quarterly net profit is -$928.00 thousand

Quarterly EBIT

-$1.03 M
SNOA quarterly earnings before interest & taxes is -$1.03 million

Quarterly EPS

-$0.63
SNOA quarterly earnings per share is -$0.63

TTM EBITDA

-$4.32 M
-$199.00 K-4.83%

December 31, 2024

Summary

Performance

3-Month Change

-4.83%

1-Year Change

-1.05%

3-Year Change

+2.86%

5-Year Change

+2.86%

SNOA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

71.86%
SNOA TTM EBITDA is higher than 71.86% of companies in Healthcare sector

High & Low

All-time High

$6.93 M
SNOA TTM EBITDA is currently -162.26% below its historical high of $6.93 million

3-Year Low

-$6.34 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
SNOA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
SNOA next earnings announcement is scheduled for Feb 7, 2025

OtherSNOAprofitabilitymetrics:

TTM Revenue

$13.97 M
SNOA TTM revenue is $13.97 million

TTM Net Income

-$3.75 M
SNOA TTM net profit is -$3.75 million

TTM EBIT

-$4.46 M
SNOA TTM earnings before interest & taxes is -$4.46 million

TTM EPS

-$3.99
SNOA TTM earnings per share is -$3.99

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$4.53 M
SNOA annual EBITDA is -$4.53 million

Annual Net Income

-$4.83 M
SNOA annual net profit is -$4.83 million

Annual Interest Expense

-
SNOA annual interest expense value is unknown

Annual Income Tax

-$196.00 K
SNOA annual income tax is -$196.00 thousand

Annual D&A

$176.00 K
SNOA annual depreciation & amortization is $176.00 thousand

SNOA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.8%-24.9%-1.1%
3 y3 years-40.4%+10.3%+2.9%
5 y5 years+58.3%+10.3%+2.9%

SNOA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-40.4%+20.6%-42.0%+66.8%-4.8%+31.9%
5 y5-year-40.7%+58.3%-547.5%+66.8%-109.1%+31.9%
alltimeall time-189.1%+79.1%-113.3%+95.6%-162.3%+80.6%

Sonoma Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-
-$998.00 K(+22.5%)
-$4.32 M(+4.8%)
Sep 2024
-
-$815.00 K(-28.1%)
-$4.12 M(-7.8%)
Jun 2024
-
-$1.13 M(-17.1%)
-$4.46 M(-1.3%)
Mar 2024
-$4.53 M(+1.8%)
-$1.37 M(+71.2%)
-$4.53 M(+6.0%)
Dec 2023
-
-$799.00 K(-31.3%)
-$4.27 M(-19.0%)
Sep 2023
-
-$1.16 M(-2.7%)
-$5.27 M(+9.6%)
Jun 2023
-
-$1.20 M(+7.4%)
-$4.81 M(+8.4%)
Mar 2023
-$4.45 M(-22.0%)
-$1.11 M(-38.2%)
-$4.44 M(-29.9%)
Dec 2022
-
-$1.80 M(+156.3%)
-$6.34 M(+16.1%)
Sep 2022
-
-$703.00 K(-14.7%)
-$5.46 M(-3.7%)
Jun 2022
-
-$824.00 K(-72.6%)
-$5.67 M(-0.6%)
Mar 2022
-$5.70 M(+76.9%)
-$3.01 M(+226.9%)
-$5.70 M(+4.3%)
Dec 2021
-
-$921.00 K(+1.0%)
-$5.46 M(+18.8%)
Sep 2021
-
-$912.00 K(+6.5%)
-$4.60 M(+32.8%)
Jun 2021
-
-$856.00 K(-69.1%)
-$3.46 M(+7.6%)
Mar 2021
-$3.22 M(+0.2%)
-$2.77 M(+4682.8%)
-$3.22 M(+56.1%)
Dec 2020
-
-$58.00 K(-126.0%)
-$2.06 M(-34.4%)
Sep 2020
-
$223.00 K(-136.4%)
-$3.15 M(-31.4%)
Jun 2020
-
-$612.00 K(-62.2%)
-$4.59 M(+42.7%)
Mar 2020
-$3.22 M(-70.4%)
-$1.62 M(+41.7%)
-$3.22 M(-24.3%)
Dec 2019
-
-$1.14 M(-6.3%)
-$4.25 M(-19.7%)
Sep 2019
-
-$1.22 M(-260.3%)
-$5.29 M(-21.8%)
Jun 2019
-
$760.00 K(-128.7%)
-$6.77 M(-37.6%)
Mar 2019
-$10.85 M(-21.1%)
-$2.65 M(+21.5%)
-$10.85 M(-15.1%)
Dec 2018
-
-$2.18 M(-19.1%)
-$12.78 M(-6.4%)
Sep 2018
-
-$2.70 M(-18.9%)
-$13.65 M(-0.2%)
Jun 2018
-
-$3.33 M(-27.4%)
-$13.68 M(-0.5%)
Mar 2018
-$13.75 M(+8.4%)
-$4.58 M(+50.1%)
-$13.75 M(+12.2%)
Dec 2017
-
-$3.05 M(+11.8%)
-$12.25 M(-3.6%)
Sep 2017
-
-$2.73 M(-19.5%)
-$12.71 M(-1.6%)
Jun 2017
-
-$3.39 M(+9.8%)
-$12.92 M(-0.4%)
Mar 2017
-$12.69 M(-12.4%)
-$3.09 M(-12.0%)
-$12.97 M(-3.8%)
Dec 2016
-
-$3.50 M(+19.3%)
-$13.49 M(-4.6%)
Sep 2016
-
-$2.94 M(-14.7%)
-$14.14 M(+9.6%)
Jun 2016
-
-$3.44 M(-4.4%)
-$12.90 M(+9.9%)
Mar 2016
-$14.48 M(+82.2%)
-$3.60 M(-13.3%)
-$11.74 M(+22.6%)
Dec 2015
-
-$4.15 M(+144.1%)
-$9.57 M(+31.5%)
Sep 2015
-
-$1.70 M(-25.3%)
-$7.28 M(+16.3%)
Jun 2015
-
-$2.28 M(+58.1%)
-$6.26 M(+57.1%)
Mar 2015
-$7.95 M(-256.5%)
-$1.44 M(-22.4%)
-$3.98 M(-179.8%)
Dec 2014
-
-$1.86 M(+173.2%)
$4.99 M(-28.0%)
Sep 2014
-
-$680.00 K(>+9900.0%)
$6.93 M(+7.1%)
Jun 2014
-
-$3000.00(-100.0%)
$6.47 M(+27.5%)
DateAnnualQuarterlyTTM
Mar 2014
$5.08 M(-225.2%)
$7.53 M(+9085.4%)
$5.08 M(-211.2%)
Dec 2013
-
$82.00 K(-107.2%)
-$4.57 M(-26.6%)
Sep 2013
-
-$1.14 M(-18.4%)
-$6.22 M(+6.6%)
Jun 2013
-
-$1.40 M(-33.8%)
-$5.84 M(+60.6%)
Mar 2013
-$4.06 M(-33.2%)
-$2.11 M(+33.9%)
-$3.63 M(+23.9%)
Dec 2012
-
-$1.58 M(+109.0%)
-$2.93 M(-17.7%)
Sep 2012
-
-$754.00 K(-193.5%)
-$3.56 M(+6.2%)
Jun 2012
-
$806.00 K(-157.2%)
-$3.36 M(-44.9%)
Mar 2012
-$6.07 M(-14.6%)
-$1.41 M(-36.2%)
-$6.10 M(+2.3%)
Dec 2011
-
-$2.21 M(+303.7%)
-$5.96 M(+4.0%)
Sep 2011
-
-$547.00 K(-71.7%)
-$5.74 M(-14.9%)
Jun 2011
-
-$1.94 M(+52.0%)
-$6.74 M(-5.1%)
Mar 2011
-$7.11 M(-6.2%)
-$1.27 M(-35.7%)
-$7.11 M(-1.1%)
Dec 2010
-
-$1.98 M(+27.4%)
-$7.19 M(+1.0%)
Sep 2010
-
-$1.55 M(-32.4%)
-$7.12 M(-7.6%)
Jun 2010
-
-$2.30 M(+69.9%)
-$7.71 M(+1.6%)
Mar 2010
-$7.58 M(-54.2%)
-$1.35 M(-29.1%)
-$7.58 M(-8.9%)
Dec 2009
-
-$1.91 M(-10.8%)
-$8.33 M(-11.3%)
Sep 2009
-
-$2.14 M(-1.7%)
-$9.38 M(-31.4%)
Jun 2009
-
-$2.18 M(+3.9%)
-$13.67 M(-16.2%)
Mar 2009
-$16.54 M(-23.7%)
-$2.10 M(-29.3%)
-$16.32 M(-17.6%)
Dec 2008
-
-$2.97 M(-53.9%)
-$19.81 M(-10.8%)
Sep 2008
-
-$6.43 M(+33.3%)
-$22.20 M(+4.4%)
Jun 2008
-
-$4.83 M(-13.6%)
-$21.26 M(-2.0%)
Mar 2008
-$21.68 M(+15.3%)
-$5.58 M(+4.1%)
-$21.68 M(-0.1%)
Dec 2007
-
-$5.36 M(-2.3%)
-$21.70 M(+2.0%)
Sep 2007
-
-$5.49 M(+4.6%)
-$21.28 M(+98.1%)
Jun 2007
-
-$5.25 M(-6.2%)
-$10.74 M(+148.2%)
Mar 2007
-$18.81 M(-6.9%)
-$5.60 M(+13.1%)
-$4.33 M(-79.8%)
Dec 2006
-
-$4.95 M(-198.0%)
-$21.42 M(+36.2%)
Sep 2006
-
$5.05 M(+333.4%)
-$15.72 M(-22.3%)
Jun 2006
-
$1.17 M(-105.1%)
-$20.23 M(-3.0%)
Mar 2006
-$20.20 M(+27.2%)
-$22.68 M(-3120.5%)
-$20.85 M(+34.6%)
Dec 2005
-
$751.00 K(+38.8%)
-$15.50 M(-2.6%)
Sep 2005
-
$541.00 K(0.0%)
-$15.91 M(-1.3%)
Jun 2005
-
$541.00 K(-103.1%)
-$16.11 M(-1.2%)
Mar 2005
-$15.88 M(-1860.3%)
-$17.33 M(-5211.8%)
-$16.31 M(-1703.9%)
Dec 2004
-
$339.00 K(0.0%)
$1.02 M(+50.0%)
Sep 2004
-
$339.00 K(0.0%)
$678.00 K(+100.0%)
Jun 2004
-
$339.00 K
$339.00 K
Mar 2004
$902.00 K(-161.4%)
-
-
Mar 2003
-$1.47 M(+898.6%)
-
-
Mar 2002
-$147.00 K
-
-

FAQ

  • What is Sonoma Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Sonoma Pharmaceuticals?
  • What is Sonoma Pharmaceuticals annual EBITDA year-on-year change?
  • What is Sonoma Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Sonoma Pharmaceuticals?
  • What is Sonoma Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Sonoma Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Sonoma Pharmaceuticals?
  • What is Sonoma Pharmaceuticals TTM EBITDA year-on-year change?

What is Sonoma Pharmaceuticals annual EBITDA?

The current annual EBITDA of SNOA is -$4.53 M

What is the all time high annual EBITDA for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals all-time high annual EBITDA is $5.08 M

What is Sonoma Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, SNOA annual EBITDA has changed by -$80.00 K (-1.80%)

What is Sonoma Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of SNOA is -$998.00 K

What is the all time high quarterly EBITDA for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals all-time high quarterly EBITDA is $7.53 M

What is Sonoma Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, SNOA quarterly EBITDA has changed by -$199.00 K (-24.91%)

What is Sonoma Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of SNOA is -$4.32 M

What is the all time high TTM EBITDA for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals all-time high TTM EBITDA is $6.93 M

What is Sonoma Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, SNOA TTM EBITDA has changed by -$45.00 K (-1.05%)